Possible scenario
Ebola Response Continues
20% Chance
Public-health officials separate the U.S. animal-testing controversy from the operational Ebola response in DR Congo. WHO, Africa CDC, and Congolese authorities continue ring vaccination and worker vaccination, reducing the risk that the article undermines confidence in licensed Ebola vaccines.
Secondary impacts
- Healthcare +0.5%
Tickers
- MRK+0.9%
- EBS+0.6%
- REGN+0.2%
Portfolio impact
S&P 500+0.0%
Each figure is the modeled move of the S&P 500 if the outcome occurs. For information only. Not investment advice.
Keeping an eye on this scenario?
Tilt can alert you when its probability or impact shifts, or send you a recommendation when it crosses a threshold.